NEW YORK, NY / ACCESSWIRE / May 30, 2017 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against BofI Holding, Inc. (“BofI” or the “Company”) (NASDAQ: BOFI) and certain of its officers, on behalf of shareholders who purchased BofI securities between April 28, 2016 and March 30, 2017, inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: http://www.bgandg.com/bofi.

This class action seeks torecover damages against Defendants for alleged violations of the federalsecurities laws under the Securities Exchange Act of 1934.

The complaint alleges that throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that: (1) BofI was engaged in unlawful conduct; (2) the abovementioned conduct, when it became known, would subject BofI to heightened regulatory scrutiny and potential criminal sanctions; and (3) consequently, BofI’s public statements were materially false and misleading at all relevant times.

On March 31, 2017, pre-market, the New York Post published an article stating in part that “federal agents are conducting a probe into possible money laundering at online lender Bank of Internet,” and that the Securities and Exchange Commission and the Treasury Department are also involved and focusing the investigation on regulatory filings made by BofI to the Office of the Comptroller of the Currency. Following this news, BofI stock dropped $1.45 per share or 5.26%, to close at $26.13 on March 31, 2017.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm’s site: http://www.bgandg.com/bofi, or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in BofI, you have until June 2, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC

Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 458907

The Company is attracting top talent with its strong Board and highly-qualified Management Team

AUSTIN, TX / ACCESSWIRE / May 30, 2017 / Bravatek Solutions, Inc. (OTC PINK: BVTK), a next generation cyber security software, hardware and solutions provider, today announced that it has retained a nationally known sales executive, Mr. Jim Brown as a Vice President of Sales to coordinate sales activity, and oversee the installation of its nationwide sales organization.

Mr. Brown is a prominent and qualified sales and marketing executive with over twenty years of sales experience with technology-based firms. Jim has an impressive track record of making things happen–including contributing large sales volumes while also leading the development of local and national sales efforts. Jim’s expertise in developing prominent sales processes, implementing effective client training strategies, and launching effective marketing initiatives should help Bravatek increase revenues while making sure clients get up and running, smoothly and efficiently. In addition to leading major corporate sales efforts, Mr. Brown has helped launch effective marketing communications programs and cloud-based software training programs for several Fortune 500 companies, including the Xerox Corporation, Comcast Business Services and United Airlines.

Bravatek projects that its domestic sales organization will grow to over a hundred technology, software, telecom services and hardware representatives by the end of 2018. These reps will represent the “best of the best” in sales, service, training and installation. Bravatek’s goal is to create the most revered team ever assembled in the cyber security software industry. The model for future growth will be based on the same model that Jim helped launch on behalf of Comcast Business Services. When Jim started there, they were generating approximately $300,000 in revenue during Year 1, only to exceed $1 billion dollars of revenue by Year 6.

Bravatek has also asked Jim to act as the Western Regional Director of Government Services, and in this capacity, Jim will oversee the implementation and management of our software implementation team. Jim will also oversee Bravatek’s Military Services Program, thereby giving leverage to Bravatek’s existing government contract vehicles, IDIQs, MSAs, etc. that are already signed, but are now capable of being rapidly implemented nationwide. Jim has over twenty years of sales and management experience and is known for excellent team-building and sales management in Internet technology, digital communications and the broadband services industries.

Jim has led sales teams that have successfully implemented technology-based solutions for municipal, corporate and military-based infrastructures. He is currently working on major cloud-based installations for municipal and corporate clients in the cities of Phoenix, Los Angeles, Palo Alto, Seattle, Salt Lake City, and Denver. Jim is also available to handle various other projects based upon Request for Proposals (RFPs) for cyber security solutions sought by those municipal, corporate and government entities.

Mr. Brown will work closely with the Bravatek executive team to present a comprehensive cyber security communication platform for United States military operations throughout the West Region with special emphasis upon email server environments.

“Bravatek Solutions, Inc.’s national and international sales initiatives have now obtained a significant marketing and sales advantage with the retention of this seasoned sales executive. Our ‘First to Market’ sales strategies will hopefully result in significant growth with sustainable sales both nationally and internationally in 2017 and beyond,” commented Bravatek Solutions, Inc.’s Chairman & CEO, Thomas A. Cellucci, PhD, MBA.

Jim’s family lives in the State of Colorado, where Jim’s wife is currently the Lt. Governor of Colorado.

About Bravatek Solutions, Inc.

Bravatek Solutions, Inc. is a high technology security solutions portfolio provider that assists corporate entities, governments and individuals protect their organizations against both physical and cyber-attacks through its offering of the most technically-advanced, cost-effective and reliable software, tools and systems.

For more information, visit www.bravatek.com.

Safe Harbor Statement

This press release contains certain “forward-looking statements”, as defined in the United States Private Securities Litigation Reform Act of 1995, that involve a number of risks and uncertainties. There can be no assurance that such statements will prove to be accurate and the actual results and future events could differ materially from management’s current expectations. The economic, competitive, governmental, technological and other factors identified in the Company’s previous filings with the Securities and Exchange Commission may cause actual results or events to differ materially from those described in the forward looking statements in this press release. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Media contact:

Bravatek Solutions, Inc.
media@bravatek.com
1.866.490.8590

SOURCE: Bravatek Solutions, Inc.

ReleaseID: 464439

NEW YORK, NY / ACCESSWIRE / May 30, 2017 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Catalyst Hedged Futures Strategy Fund Class A, Class C and Class I (“Catalyst Futures Fund” or the “Company”) (NASDAQ: HFXAX; NASDAQ: HFXCX; NASDAQ: HFXIX) securities and certain of its officers, on behalf of a class who purchased Catalyst Futures Fund securities between November 1, 2014 and April 28, 2017 (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: www.bgandg.com/hfxax.

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1933.

The complaint alleges that Catalyst Futures Fund was recognized as a mutual fund, defendants marketed and sold shares of the Fund as low-risk, low-volatility investment with minimal correlation to the U.S. equity market. The Prospectuses for the Fund stated that the Fund “places a strong focus on risk management that is intended to provide consistency of returns and to mitigate the extent of losses …. [T]he Fund employs strict risk management procedures to adjust portfolio exposure as necessitated by the changing market conditions.” The complaint alleges that these statements and other like them in the Fund’s Prospectuses and Registration Statements issued in connection with the offerings of Fund shares were inaccurate statements of material fact because they did not disclose that the Catalyst Futures Fund continued to invest as if it were a hedge fund, taking massive directional bets against U.S. stock market indices through complex derivative instruments, thereby exposing investors to the heightened risk of loss capital.

Subsequently, in February 2017, the Catalyst Futures Fund dropped in the net asset value (“NAV”) of Fund shares, losing $600 million over a few days’ time. Between February 2 and February 15, 2017, the NAV for the Fund’s Class A shares dropped over 15%, from $10.59 per share to $8.98. Numerous news sources started reporting on the erosion in Fund value, describing the loss as a “‘melt-down'” and saying that the Fund was “‘blowing up.'” According to the complaint, Catalyst Futures Fund had taken out substantial option contracts that effectively “shorted” the S&P 500, consequently the Fund had made a directional bet that the general equity market would not rise significantly in value. As the market rallied around the time these options were set to expire in mid-February 2017, the Fund experienced rapidly accelerating losses, as it had little time for the market to reverse itself and for the bet to return to profitability. As these undisclosed risks occurred, investors suffered hundreds of millions of dollars in losses, with the value of Fund assets dropping over $1 billion since early 2017. Between February 2, 2017 and March 15, 2017, the NAV of the Fund’s Class A shares, Class C shares and Class I shares has dropped roughly 21%, or $2.22 per share, $2.16 per share and $2.23 per share, respectively.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm’s site: www.bgandg.com/hfxax or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Catalyst Futures Fund you have until June 27, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC

Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 461438

NEW YORK, NY / ACCESSWIRE / May 30, 2017 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Synchronoss Technologies, Inc. (“Synchronoss” or the “Company”) (NASDAQ: SNCR) and certain of its officers, and is on behalf of a class consisting of all persons or entities who purchased Synchronoss securities between December 6, 2016 through April 26, 2017, both dates inclusive (the “Class Period”). Such investors are advised to join this case by visiting the firm’s site: http://www.bgandg.com/sncr.

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the “Exchange Act”).

The Complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, and failed to disclose that: (1) Synchronoss would not be able to meet revenue guidance provided to investors; (2) as a result, Synchronoss would need to revise its prior guidance; and (3) consequently defendants’ statements about Synchronoss’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

On April 27, 2017, pre-market, Synchronoss revealed that both its Chief Executive Officer, Ronald Hovsepian, and Chief Financial Officer, John Frederick, would be stepping down and informed investors that both would “pursue other interests.” Synchronoss also said that it “”expects total revenue for the first quarter of 2017 to be $13 million to $14 million less than the company’s previously announced guidance” and that “[o]perating margins are expected to be 8% to 10%, which are less than previously announced guidance.” Following these announcements, Synchronoss stock has dropped as much as $12.10 per share, or 49.15%, during intraday trading on April 27, 2017.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm’s site: http://www.bgandg.com/sncr, or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Synchronoss, you have until June 30, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC

Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 461606

Extreme Reactions to President Trump Signal a Shift in How Americans Cope

DALLAS, TX / ACCESSWIRE / May 30, 2017 / While other psychiatrists have attempted to analyze President Donald Trump’s personality from afar, psychiatrist and author Colin A. Ross, M.D. is turning his attention to the reactions the President elicits. In his new satirical book, The Trump Card: A Psychiatrist Analyzes Reactions to Donald Trump (ISBN: 978-0-9986601-2-7), Dr. Ross suggests that an individual’s response to President Trump reveals so much about their subconscious mind and thinking process that a Trump card should be placed in the Rorschach Ink Blot Test.

The Trump Card’s political satire is focused on what Dr. Ross calls the uninformed, polarized reactions to the President on both the left and the right. He laments that empathy has been devalued as politics deteriorates into an endless series of personal attacks, emotional reactions and behavior that would get an adolescent sent to the principal’s office.

To cope, Americans seek the safety of like-minded people and insulate themselves from those with differing views. The echo chamber exacerbates extremism.

“President Trump is not the problem – he is a symptom of the problem,” said Dr. Ross. According to Dr. Ross, the underlying problems that are contributing to radical changes in our social norms existed before the Trump Presidency and will no doubt continue to exist after it.

Dr. Ross says there is plenty of blame to go around:

The failure of liberal arts education to teach people how to think critically.

The absence of historical memory even for recent events.

The collapse of journalistic standards that has ushered in an era of fake news and emotional reactions that masquerade as political commentary.

Extreme political polarization.

The Trump Card is an equal opportunity political satire and does not discriminate on the basis of political affiliation. Dr. Ross lambasts both the left and the right, touching on President Trump’s relationship with Russian President Vladimir Putin, former President Obama’s deportations, the public’s inability to discern fake news and the folly of body language experts.

According to Ross, American politics is now just one more reality TV show, which may be good for ratings, but not for the health of the country. In the chapter titled, “What I Would Tell Trump If I was His Advisor,” Dr. Ross writes.

“It’s all about the ratings, whether it’s The Apprentice or the Real Live Presidential Race Show. What does it take to get ratings? The more outrageous, the more over-the-top, the better. You played the game perfectly, it turns out…So here’s what I can’t figure out – is all this buffoon behavior just you, or is it strategy? Is there another Donald behind the reality TV mask? A President even?”

The Trump Card: A Psychiatrist Analyzes Reactions to Donald Trump is available through Amazon at https://www.amazon.com/Trump-Card-Psychiatrist-Analyzes-Reactions/dp/0998660116. Download a high-resolution image of the book jacket at www.dpkpr.com/files/659/.

About the Author

Colin A. Ross, M.D. is the author of over 200 papers in professional journals, most of them dealing with dissociation, psychological trauma and multiple personality disorder. He is a Past President of the International Society for the Study of Trauma and Dissociation. For more information about Dr. Ross and the Colin A. Ross Institute for Psychological Trauma, visit www.rossinst.com.

SOURCE: Colin A. Ross Institute

ReleaseID: 464359

NEW YORK, NY / ACCESSWIRE / May 30, 2017 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Inventure Foods, Inc. (“Inventure” or the “Company”) (NASDAQ: SNAK) and certain of its officers, on behalf of shareholders who purchased Inventure securities between March 3, 2016, and March 16, 2017, both dates inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: http://www.bgandg.com/snak.

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

On March 9, 2017, Inventure revealed that it would delay its annual filing on Form 10-K for its fiscal year ended December 31, 2016 and that it expected to file a notification of late filing on Form 12b-25 with the SEC to obtain a 15-day extension of the filing deadline for the Form 10-K. Inventure said it needed time to complete certain intangible asset and goodwill impairment tests, and that, consequently, its independent registered public accounting firm had not finished its audit for its financial statements and the assessment of the its internal control over financial reporting.

On March 16, 2017, after-market hours, Inventure filed a notice with the SEC revealing that it would delay its 2016 fiscal year annual report. Inventure also said that it believes its statements of operations contained in the annual report “will differ materially” from those reported for its fourth quarter and fiscal year 2015. Following this news, Inventure stock dropped $0.13 per share, or 2.5%, to close at $4.91 per share on March 17, 2017, and continued to drop in the following trading days, $0.48 per share, or 9.7%, on March 20, 2017, and $0.41 per share, or 9.2%, on March 21, 2017, to close at $4.02 per share on March 21, 2017.

The complaint alleges that throughout the Class Period, Defendants made false and/or misleading statements, and failed to disclose that: (1) Inventure lacked adequate internal controls over accounting and financial reporting; (2) as a result, Inventure’s statements of operations in its fiscal year 2015 results press release contained improper figures; and (3) consequently, Defendants’ statements about Inventure’s business, operations, and prospects were false and misleading and/or lacked a reasonable basis.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm’s site: http://www.bgandg.com/snak, or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Inventure, you have until May 30, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 464241

NEW YORK, NY / ACCESSWIRE / May 30, 2017 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against U.S. Concrete, Inc. (“U.S. Concrete” or the “Company”) (NASDAQ: USCR) and certain of its officers, on behalf of shareholders who purchased U.S. Concrete securities between March 6, 2015 and March 23, 2017, both dates inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: http://www.bgandg.com/uscr.

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

The complaint alleges that throughout the Class Period, defendants made materially false and misleading statements and failed to disclose that: (1) U.S. Concrete lacked effective internal controls over financial reporting; and (2) consequently, defendants’ statements about U.S. Concrete’s business, operations, and prospects were false and misleading and/or lacked a reasonable basis.

On March 24, 2017, U.S. Concrete revealed the resignation of its Chief Financial Officer, Joseph Tusa, and advised investors that it had dismissed its previous auditor, Grant Thornton, and engaged Ernst & Young as its new public accounting firm. Following this news, U.S. Concrete stock has dropped as much as $7.30 per share, or 10.94%, during intraday trading on March 24, 2017.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm’s site: http://www.bgandg.com/uscr, or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in U.S. Concrete, you have until May 30, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 464242

NEW YORK, NY / ACCESSWIRE / May 30, 2017 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against U.S. Physical Therapy, Inc. (“U.S. Physical Therapy” or the “Company”) (NYSE: USPH) and certain of its officers, on behalf of shareholders who purchased U.S. Physical Therapy securities between May 8, 2014 through March 16, 2017, inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: http://www.bgandg.com/usph.

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

The complaint alleges that, throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that: (1) U.S. Physical Therapy had a material weakness in its internal controls over accounting and financial reporting; (2) U.S. Physical Therapy improperly accounted for redeemable non-controlling interests of acquired partnerships in violation of Generally Accepted Accounting Principles; (3) U.S. Physical Therapy’s financial statements for the years ended December 31, 2015 and 2014, and all quarters within 2014 and 2015, and the first three quarters of 2016 contained material errors; and (4) consequently, defendants’ statements about U.S. Physical Therapy’s business, operations, and prospects were false and misleading and/or lacked a reasonable basis.

On March 16, 2017, U.S. Physical Therapy revealed that it had discovered an accounting error. The Company stated that “it was determined that the Company’s historical accounting for redeemable non-controlling interests of acquired partnerships was incorrect due to the fact that those partnership agreements contain a provision that makes the non-controlling interests mandatorily redeemable and, thus incorrectly classified.” U.S. Physical Therapy also said that “[m]anagement has concluded that this error will result in the reporting of a material weakness in internal controls over financial reporting as they relate to this issue and that, as a result, ineffective internal controls over financial reporting. The error will require the restatement of previously issued financial statements.” Following this news, U.S. Physical Therapy stock has dropped as much as $7.75 per share, or 10.51%, during intraday trading on March 16, 2017.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm’s site: http://www.bgandg.com/usph, or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in U.S. Physical Therapy, you have until May 30, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 464243